Relationship between cataract extraction and IOP

Article

Cataract extraction could reduce complications in XFS

"We believe that timely cataract extraction could prevent complications of expected exfoliation syndrome (XFS)," asserted Professor Petja Vassileva when discussing the work she and her colleague, Dr M. Sredkova, performed on the influence of cataract extraction on intraocular pressure (IOP) in patients with XFS and exfoliation glaucoma (XFG), recently presented at the 2011 ESCRS Congress.

Debated topic

There has been much debate on the issue of management of coexisting glaucoma and cataract over the years with an emphasis on primary angle-closure and primary open-angle glaucoma (POAG). "There is a lot of data in the literature, starting in the middle of the 90s with the influence of cataract extraction, especially phaco, on the intraocular pressure (IOP)," Prof. Vassileva added.1

Important clinical implications

"XFS is an age-related systemic disorder and all of the manifestations are severe and have important clinical implications," she said. This cause of glaucoma is common and easily identifiable. "We all know that XFS is typical above the age of 50 and its prevalence increases with age. It's usually associated with a combination of glaucoma with increased pressure and an increased prevalence of cataract," she said. "Many patients with XFS have elevated IOP leading to a development of glaucoma and 50% of eyes undergo cataract surgery after trabeculectomy."

Prof. Vassileva explained that several important but simple questions should be posed in relation to the management of coexisting glaucoma and cataract, for example, should cataract surgery alone be performed? Should cataract surgery be performed first followed by glaucoma surgery, if required? Or, glaucoma surgery first and then definitely follow with cataract surgery?

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences

All rights reserved.